Discussion  by unknown
egy. Discordant pursuit of BVR in borderline candidates is
more frequent than the discordant pursuit of UVR, likely
driven by an intuitive notion that “two ventricles are better
than one.” Discordant BVR is more costly in survival terms
than discordant UVR. Use of the UVR-SA value will iden-
tify infants for whom UVR may be better than attempting
BVR in the face of challenging morphologic, functional,
and pathologic features. The UVR-SA is freely available on
the CHSS Web site (www.chss.org).
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Discussion
Dr Edward L. Bove (Ann Arbor, Mich). I would like to thank Dr
Hickey and his coauthors from the CHSS for an excellent study
with a new, at least to me, statistical evaluation tool. In this
presentation, the authors have asked the age-old question: “Is a
high-risk BVR better than a low-risk UVR approach?” Despite the
substantial decline in early mortality for univentricular approaches,
most centers still desire to push borderline patients to a BVR,
believing that it is safer and affords better long-term outcome. The
authors have documented that the first assumption is not always
correct, although the second still remains uncertain. Further com-
plicating this decision process is the realization that, at least for the
types of patients in this particular analysis, namely, those with
critical LVOT obstruction, the single-ventricle approach perhaps
offers the best outcomes among many variants of hypoplastic left
heart syndrome.
The authors performed an exhaustive analysis of multiple risk
factors for death for both UVR and BVR and then formed a
UVR-SA tool that allowed them to reanalyze predicted survival for
those whose repair was either concordant or discordant using
predictive formulas previously published. This model was further
refined and used to predict an optimal survival path for the patients
in the analysis.
Although there are multiple intriguing findings among these
data, the authors found that discordant decision-making, namely,
pursuing BVR when UVR had a higher predicted survival or vice
versa, costs lives. More important, a discordant BVR decision is
more costly than a UVR one. The inference is that the marginal left
heart, for whatever reason, has little or no room to compensate and
transfers all the risk up front. Equally important, although not
addressed here, is the potential that many BVR survivors may also
face repeated valve replacement procedures and pulmonary hyper-
tension in their later years. I have 2 questions for Dr. Hickey.
It seems from the analysis of their paper that a smaller mitral
valve annulus was a risk factor only for UVR. Others have re-
ported that the mitral valve size was strongly predictive of out-
come for BVR. Could the authors provide some insight regarding
the influence of the mitral valve, either size or function, on survival
for BVR patients?
Second, do the authors believe that the more liberal use of
Ross–Konno procedures, either with or without arch repair as
Hickey et al Surgery for Congenital Heart Disease
1436 The Journal of Thoracic and Cardiovascular Surgery ● December 2007
CH
D
needed or even resection of EFE, might improve survival for
BVR?
I thank Dr. Hickey for an excellent presentation.
Dr. Hickey. Thank you very much, Dr. Bove, for your com-
ments and your questions. The issue with the mitral valve annulus
is intriguing, because, as you point out, it was identified as a risk
factor for death following univentricular repair, which is clearly a
surprise. We explored this further, and our conclusions are as
follows.
The mitral annular Z scores as a risk factor for univentricular
repair do not correlate with either mitral stenosis or mitral regur-
gitation in this cohort. Therefore, this variable, although represent-
ing the mitral annulus, is not necessarily a functional variable. It is
a morphological dimension that correlates strongly with overall
left-sided structural hypoplasia. So it correlates with dimensions of
the LV outflow tract and the ventricular size and ventricular
hypoplasia. So it is in some ways misleading that it is the mitral
annulus. It is, we feel, a variable representing the overall dimen-
sion and degree of left-sided hypoplasia.
So why is it not a risk factor for biventricular repair? Well, the
answer to that is that we obviously looked at and explored the
potential for both functional regurgitation or stenosis as a risk
factor after biventricular repair, including mitral morphology and
dimensions. All of these variables were overshadowed in our
statistical analysis by more robust variables—namely, the degree
of LV dysfunction—and particularly the severity of endocardial
fibroelastosis or thickening, which is an extremely strong predictor
of poor prognosis after biventricular repair. So although we don’t
deny that mitral valve variables have been reported as important in
other series, here they have been overshadowed by other functional
and morphologic left-sided variables.
In regard to your second question and the use of neonatal
Ross–Konno procedures, we have been looking at the index pro-
cedure as the intention to treat. Invariably in our series this was
either through balloon aortic valvotomy or surgical valvotomy,
with only a minority of more complex repairs (namely, 2 Yasui
and 5 index Ross–Konno procedures). A number of other Ross–
Konno procedures were undertaken subsequently as repeat
interventions—in fact, a total of 30. Overall outcome for these was
66% survival at 5 years. Now, of course there are reports of further
improved survival with Ross–Konno procedures, and this may
translate into a further bias towards management. However, at the
same time as that survival will have improved with Ross–Konno
procedures, survival also will have improved over the intervening
decade with staged Norwood palliation, for example. So the only
way of actually determining whether index Ross–Konno results in
improved BVR survival is to undertake a contemporary investiga-
tion in which we enroll a higher proportion of Ross–Konno pro-
cedures and complex repairs. In fact, that is an investigation that
the CHSS are looking at now with our latest LV outflow tract
series.
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